Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials
First dose of ETC-159 administered in Phase 1B of clinical trials, advancing the development of this drug to treat solid
Read MoreFirst dose of ETC-159 administered in Phase 1B of clinical trials, advancing the development of this drug to treat solid
Read MoreSINGAPORE, July 24, 2020 – (ACN Newswire) – MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been
Read More